Default: Drug Delivery

ISSN: 1071-7544

Journal Home

Journal Guideline

Drug Delivery Q1 Unclaimed

Informa Healthcare United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Delivery is a journal indexed in SJR in Medicine (miscellaneous) and Pharmaceutical Science with an H index of 95. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1440 €. The scope of the journal is focused on drug delivery systems, drug targeting. It has an SJR impact factor of 1,155 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,155.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1440 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Drug Delivery

1,155

SJR Impact factor

95

H Index

119

Total Docs (Last Year)

642

Total Docs (3 years)

8298

Total Refs

4560

Total Cites (3 years)

641

Citable Docs (3 years)

6.69

Cites/Doc (2 years)

69.73

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Drug delivery systems Drug targeting



Best articles by citations

Formulation and Biopharmaceutical Evaluation of Osmotic Matrix Tablets of Diclofenac Sodium

View more

Development of Mucoadhesive Dosage Forms of Buprenorphine for Sublingual Drug Delivery

View more

Mucoadhesive Tablets for Buccal Administration Containing Sodium Nimesulide

View more

Particle-Mediated Intravascular Delivery of Oligonucleotides to Tumors: Associated Biology and Lessons from Genotherapy

View more

Microsphere-Mediated Targeted Gene Therapy of Solid Tumors

View more

A Stability Test of Liposome Preparations Using Steady-State Fluorescent Measurements

View more

Effect of Nicotinic Acid Conjugated to DNA-Transfecting Complexes Targeted at the Transferrin Receptor of HeLa Cells

View more

Receptor-Mediated Gene Delivery to HepG2 Cells by Ternary Assemblies Containing Cationic Liposomes and Cationized Asialoorosomucoid

View more

Design and Study of Rifampicin Oral Controlled Release Formulations

View more

Development and Characterization of Mucoadhesive Microspheres Bearing Salbutamol for Nasal Delivery

View more

Altered Pharmacokinetics and Liver Targetability of Methotrexate by Conjugation with Lactosylated Albumins

View more

A Microsphere-Liposome (Microplex) Vector for Targeted Gene Therapy of Cancer. II. In Vivo Biodistribution Study in a Solid Tumor Model

View more
SHOW MORE ARTICLES

Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies

View more

Treatment of Focal Cerebral Ischemia with Liposomal Nerve Growth Factor

View more

In Vivo Absorption Studies of Insulin from an Oral Delivery System

View more

Poly (Lactide-co-Glycolide) Nanoparticles Containing Coumarin-6 for Suppository Delivery: In Vitro Release Profile and In Vivo Tissue Distribution

View more

Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1

View more

Reverse Biomembrane Vesicles for Effective Controlled Delivery of Doxorubicin HCl

View more

Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration

View more

Effect of Formulation Variables on the Percutaneous Permeation of Ketoprofen from Gel Formulations

View more

Elastin-like polypeptides and their applications in anticancer drug delivery systems: a review

View more

Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy

View more

Stereoselective Disposition of Ibuprofen Enantiomer Sustained Release Microspheres in Rats: I. Bioavailability Considerations

View more

Naproxen glycine conjugate-synthesis, pharmaceutical preformulation and pharmacodynamic evaluation

View more

FAQS